Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues

E-ISSN： 2212-3970|1|2|163-170

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.1, Iss.2, 2006-06, pp. : 163-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical rationale for synergistic interaction of pemetrexed and cytotoxic nucleoside analogues

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 571-575

Spandidos Publications

Access to resources Recommend Favorite

Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 8, 2013-10 ,pp. : 1204-1216

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Purine Nucleoside Analogues for Hematological Malignancies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 123-136

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Anticancer Cytotoxic Agents

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-03 ,pp. : 93-121

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in the Epidemiology of Prostate Cancer

By Mettlin C.

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 340-347

Elsevier

Access to resources Recommend Favorite